BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3592453)

  • 1. [Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
    Leport C; Vildé JL; Katlama C; Regnier B; Mathéron S; Saimot AG
    Ann Med Interne (Paris); 1987; 138(1):30-3. PubMed ID: 3592453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral toxoplasmosis in patients with AIDS.
    Rossitch E; Carrazana EJ; Samuels MA
    Am Fam Physician; 1990 Mar; 41(3):867-73. PubMed ID: 2407076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opportunistic Toxoplasma gondii infections].
    Reinert P; Bernaudin F
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():949-51. PubMed ID: 3833107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral toxoplasmosis in patients with AIDS].
    Altés J; Salas A; Ricart C; Villalonga C; Riera M; Casquero P
    Arch Neurobiol (Madr); 1989; 52 Suppl 1():121-6. PubMed ID: 2637654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
    Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL
    Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
    Gilman TM; Boylen CT; Sattler FR
    Clin Pharm; 1989 Feb; 8(2):84, 87. PubMed ID: 2645082
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain lesions in patients with acquired immunodeficiency syndrome.
    Bishburg E; Eng RH; Slim J; Perez G; Johnson E
    Arch Intern Med; 1989 Apr; 149(4):941-3. PubMed ID: 2705847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary toxoplasmosis in AIDS. Report of 3 cases].
    Knani L; Bouslama K; Varette C; Gonzalez Canali G; Cabane J; Lebas J; Imbert JC
    Ann Med Interne (Paris); 1990; 141(5):469-71. PubMed ID: 2256591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
    del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G
    Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
    Timsit JC; Bloch-Michel E
    J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
    Langmann P; Klinker H; Richter E
    Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
    [No Abstract]   [Full Text] [Related]  

  • 12. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient.
    Westblom TU; Belshe RB
    Scand J Infect Dis; 1988; 20(5):561-3. PubMed ID: 3222671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
    González-Clemente JM; Miró JM; Pedrol E; Alvarez R; Gatell JM; Mallolas J; Graus F; Mercader JM; Guelar A; Jiménez de Anta MT
    Med Clin (Barc); 1990 Oct; 95(12):441-6. PubMed ID: 2084411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancytopenia induced by pyrimethamine during treatment of cerebral toxoplasmosis associated with AIDS. Role of dihydrofolate reductase inhibitors].
    Boudes P; Zittoun J; Sobel A
    Ann Med Interne (Paris); 1990; 141(2):183-6. PubMed ID: 2353761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular toxoplasmosis in AIDS].
    Chakroun M; Meyohas MC; Pelosse B; Zazoun L; Vacherot B; Derouin F; Leport C
    Ann Med Interne (Paris); 1990; 141(5):472-4. PubMed ID: 2256592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
    Rolston KV; Hoy J
    Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
    Faucher B; Moreau J; Zaegel O; Franck J; Piarroux R
    J Antimicrob Chemother; 2011 Jul; 66(7):1654-6. PubMed ID: 21459896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm].
    Montero A; Cohen JE; Martínez DP; Giovannoni AG
    Medicina (B Aires); 1998; 58(5 Pt 1):504-6. PubMed ID: 9922485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
    Sparacia G; Brancatelli G; Sarno C; De Maria M; Lagalla R; Filosto L
    Radiol Med; 1998; 96(1-2):23-8. PubMed ID: 9819614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.